ArticleCurrent psychology (New Brunswick, N.J.)2021
Global validation of the Coronavirus Anxiety Scale (CAS).
Article in Current psychology (New Brunswick, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Reducing fear and avoidance of memory loss improves mood and social engagement in community-based older adults: a randomized trial.BMC geriatrics · 2023Trial
- Validation of the Arabic coronavirus anxiety scale among mothers of infants in Saudi Arabia.Maternal health, neonatology and perinatology · 2026Article
- Depression, Anxiety, and Stress Symptoms in Women with Rheumatic Disease of Reproductive Age: Lessons from the COVID-19 Pandemic.Journal of clinical medicine · 2025Article
- Development and validation of the pandemic fear perception and adaptability scale.Frontiers in psychology · 2025Article
- Choosing a COVID-19 vaccination site might be driven by anxiety and body vigilance.Open medicine (Warsaw, Poland) · 2024Article
- Article
- Fear and Trembling While Working in a Pandemic: an Exploratory Meta-Analysis of Workers' COVID-19 Distress.Occupational health science · 2023Review
- Short report: COVID-19-related anxiety is associated with mental health problems among adults with rare disorders.Research in developmental disabilities · 2022Article
- Assessing anxiety during the COVID-19 delta epidemic: Validation of the Chinese coronavirus anxiety scale.Frontiers in psychology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The five-item Coronavirus Anxiety Scale (CAS) was found to be a useful and valid mental health screener. Participants in the respective surveys were mostly from single countries such as the US, Turkey, Mexico, or Brazil. However, a cross-cultural re-examination is lacking. This study fills this gap. In several multigroup confirmatory factor analyses with 25 countries from five continents as groups, sex and age as groups, and different stages of concern with COVID-19 infection, CAS was found to be invariant across all groups; this indicates that CAS is appropriate for meaningfully comparing the results across different groups. On a global basis, Coronavirus anxiety did not differ between female and male participants. Regarding age, however, younger individuals suffered more from anxiety of the pandemic. Individualistic cultures and those with low power distance such as in the Western hemisphere had higher COVID-19 anxiety. CAS values were also higher for those individuals who had been infected by COVID-19, those whose relatives had been infected, and those who experienced COVID-19-related death in the family. Overall, CAS is a parsimonious, valid, and reliable mental health screener on a global basis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.